Riozen Pharmaceutical Private Limited
Manufactures chemicals, compounds, and pharmaceuticals since 2016.
2016 | Visakhapatnam, Andhra Pradesh (India) | Active
Riozen Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -71.70%
- Profit Growth -80.89%
- Ebitda -69.23%
- Net Worth 0.31%
- Total Assets -4.86%
About Riozen Pharmaceutical
Riozen Pharmaceutical Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 November 2016 (Eight years and five months 11 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jagdeep Bansal, Smita Samal, Rajesh Patra, and One other member serve as directors at the Company.
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999AP2016PTC104381
- Company No.
104381
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Pharma
Riozen Pharmaceutical Private Limited
Explore comprehensive data for Riozen Pharmaceutical Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Riozen Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdeep Bansal  | Director | 02-Nov-2016 | Current |
| Smita Samal | Director | 02-Nov-2016 | Current |
| Rajesh Patra | Director | 02-Nov-2016 | Current |
| Kuldeep Bansal | Director | 02-Nov-2016 | Current |
Financial Performance of Riozen Pharmaceutical.
Riozen Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 71.7% decrease. The company also saw a substantial fall in profitability, with a 80.89% decrease in profit. The company's net worth moved up by a moderate rise of 0.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riozen Pharmaceutical?
Unlock access to Riozen Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cannamix Private LimitedJagdeep Bansal is a mutual person
Riocure Pharmaceuticals Private LimitedRajesh Patra is a mutual person
- Bansal Infraprojects Private Limited
Jagdeep Bansal is a mutual person
- Bright Infratech Private Limited
Jagdeep Bansal is a mutual person
- Bansal Infrastructures Private Limited
Jagdeep Bansal is a mutual person
- Suryodya Hotel And Resorts Private Limited
Jagdeep Bansal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Riozen Pharmaceutical?
Unlock and access historical data on people associated with Riozen Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riozen Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riozen Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Riozen Pharmaceutical
Recent activity within the organization
- Annual General Meeting
Riozen Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Riozen Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
- Director Appointment
Jagdeep Bansal was appointed as a Director was appointed as a Director on 02 Nov 2016 & has been associated with this company since 8 years 5 months .
- Director Appointment
Smita Samal was appointed as a Director was appointed as a Director on 02 Nov 2016 & has been associated with this company since 8 years 5 months .
- Director Appointment
Rajesh Kumar Patra was appointed as a Director was appointed as a Director on 02 Nov 2016 & has been associated with this company since 8 years 5 months .
- Director Appointment
Kuldeep Bansal was appointed as a Director was appointed as a Director on 02 Nov 2016 & has been associated with this company since 8 years 5 months .
Frequently asked questions
What is the Incorporation or founding date of Riozen Pharmaceutical Private Limited?
Riozen Pharmaceutical Private Limited was incorporated on 02 Nov 2016.
What is authorized share capital and paid-up capital of Riozen Pharmaceutical Private Limited?
The authorized share capital of Riozen Pharmaceutical Private Limited is ₹ 2.50 M and paid-up capital is ₹ 2.50 M.
Who are the current board members & directors of Riozen Pharmaceutical Private Limited?
Currently 4 directors are associated with Riozen Pharmaceutical Private Limited.
- Jagdeep Bansal
- Smita Samal
- Rajesh Kumar Patra
- Kuldeep Bansal
What is the registered address of Riozen Pharmaceutical Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Riozen Pharmaceutical Private Limited is 1-1-193 Mvp Colony Sector-11 12 Indira Nagar, Pedawaltair India, Visakhapatnam, Andhra Pradesh, 530017.
What is the corporate identification number (CIN) and company number of Riozen Pharmaceutical Private Limited?
The corporate identification number (CIN) of Riozen Pharmaceutical Private Limited is U74999AP2016PTC104381 and the company number is 104381 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Riozen Pharmaceutical Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Riozen Pharmaceutical Private Limited has fallen by -71.70%.
What change has been observed in the net worth of Riozen Pharmaceutical Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Riozen Pharmaceutical Private Limited has experienced an upsurge of 0.31%.
When was the last Balance Sheet of Riozen Pharmaceutical Private Limited filed with the ROC?
The most recent Balance Sheet for Riozen Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records